Caribou Biosciences (CRBU) Debt Ratio (2020)

Caribou Biosciences' (CRBU) quarterly Debt Ratio came in at 0.03 in Q4 2020.

Caribou Biosciences (CRBU) Debt Ratio (2020) Analysis & Trends

Caribou Biosciences (CRBU) has 1 years of Debt Ratio data on file, last reported at 0.03 in Q4 2020.

On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.03 in Q4 2020; TTM through Dec 2020 was 0.03, a N/A change from a year earlier, with the FY2020 full-year figure at 0.03, changed N/A from the prior year.
Debt Ratio for Q4 2020 stood at 0.03.
Over the last five years, Debt Ratio for CRBU reached as high as 0.03 in Q4 2020 and fell as low as 0.03 in Q4 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	1.41
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	0.11
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	0.05
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Caribou Biosciences	156.25 Mn	38.63 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2020	0.03